3 Results for "

chemotherapy-induced senescence

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "chemotherapy-induced senescence" in MCE Product Catalog:

Cat. No.: HY-150124
CAS No.: 939769-93-4
Purity:  98.79%
Target:  

Integrin Apoptosis

Research Areas:  

Cancer

K34c is a potent and selective α5β1 integrin antagonist. By inhibiting α5β1 integrin, K34c reduces chemotherapy-induced premature senescence and promotes apoptosis. K34c can be used in glioblastoma research .
loading...
    loading...
Cat. No.: HY-150124A
CAS No.: 2986315-25-5
Target:  

Integrin Apoptosis

Research Areas:  

Cancer

K34c hydrochloride is a potent and selective α5β1 integrin antagonist. By inhibiting α5β1 integrin, K34c hydrochloride reduces chemotherapy-induced premature senescence and promotes apoptosis. K34c hydrochloride can be used in glioblastoma research .
loading...
    loading...
Cat. No.: HY-182898
CAS No.: 3051812-84-8
Target:  

Apoptosis Glycosidase

Research Areas:  

Inflammation/Immunology

Gal-dMor-Gem is a selective senescent cell scavenger, Apoptosis inducer, and a prodrug of Gemcitabine (HY-17026). Gal-dMor-Gem releases Gemcitabine upon activation by Esterases and β-gal. Gal-dMor-Gem reduces SA-β-gal, preferentially induces apoptosis in senescent cells, regulates apoptosis-related proteins, accumulates in senescent tissues, and ameliorates senescence-related organ phenotypes. Gal-dMor-Gem is applicable to research on chemotherapy-induced senescence .
loading...
    loading...